(HRL) Hormel Foods - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4404521001
HRL: Meat, Nuts, Canned, Goods, Snacks, Food
Hormel Foods Corporation (NYSE:HRL) is a storied player in the food industry, operating with a diversified portfolio that spans multiple segments: Retail, Foodservice, and International. This structure allows the company to cater to a broad spectrum of consumers and businesses, ensuring resilience across varying market conditions. With a market capitalization of over $16 billion, Hormel commands significant scale and stability, underpinned by a P/E ratio of 19.86 and a forward P/E of 17.70, signaling moderate valuation expectations.
The companys product lineup is extensive, encompassing perishable items such as fresh meats, sausages, and refrigerated meals, alongside shelf-stable offerings like canned goods, nut butters, and snacks. This diversification not only mitigates risk but also positions Hormel to capitalize on evolving consumer preferences, such as the growing demand for convenient and nutritious food options. Their brands, including SPAM, Jennie-O, and Skippy, are household names, reflecting a strong portfolio that drives consistent revenue streams.
Founded in 1891, Hormel Foods has cultivated a legacy of innovation and reliability. Its financial health is evident in a price-to-book ratio of 2.00 and a price-to-sales ratio of 1.34, indicating a balance between asset efficiency and revenue generation. These metrics are particularly relevant for investors assessing the companys operational efficiency and growth potential.
Hormels international presence further underscores its strategic reach and adaptability. By maintaining a robust distribution network through sales personnel, brokers, and distributors, the company ensures wide market penetration. This global outlook, combined with a strong brand ecosystem, positions Hormel Foods as a formidable competitor in the packaged foods and meats industry, offering investors a blend of stability and growth opportunities.
Additional Sources for HRL Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
HRL Stock Overview
Market Cap in USD | 15,947m |
Sector | Consumer Defensive |
Industry | Packaged Foods |
GiC Sub-Industry | Packaged Foods & Meats |
IPO / Inception | 1990-01-02 |
HRL Stock Ratings
Growth 5y | -48.8% |
Fundamental | 18.1% |
Dividend | 64.7% |
Rel. Strength Industry | -16.1 |
Analysts | 3/5 |
Fair Price Momentum | 27.31 USD |
Fair Price DCF | 37.42 USD |
HRL Dividends
Dividend Yield 12m | 3.76% |
Yield on Cost 5y | 3.04% |
Annual Growth 5y | 3.97% |
Payout Consistency | 100.0% |
HRL Growth Ratios
Growth Correlation 3m | -79.6% |
Growth Correlation 12m | -58.9% |
Growth Correlation 5y | -73% |
CAGR 5y | -4.61% |
CAGR/Max DD 5y | -0.10 |
Sharpe Ratio 12m | 0.72 |
Alpha | -14.13 |
Beta | 0.12 |
Volatility | 21.49% |
Current Volume | 2700.5k |
Average Volume 20d | 2841.7k |
As of March 15, 2025, the stock is trading at USD 29.54 with a total of 2,700,525 shares traded.
Over the past week, the price has changed by -1.34%, over one month by +3.79%, over three months by -7.77% and over the past year by -9.18%.
Neither. Based on ValueRay Fundamental Analyses, Hormel Foods is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 18.10 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HRL as of March 2025 is 27.31. This means that HRL is currently overvalued and has a potential downside of -7.55%.
Hormel Foods has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold HRL.
- Strong Buy: 1
- Buy: 0
- Hold: 9
- Sell: 2
- Strong Sell: 0
According to ValueRays Forecast Model, HRL Hormel Foods will be worth about 29.5 in March 2026. The stock is currently trading at 29.54. This means that the stock has a potential downside of -0.17%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 31.4 | 6.4% |
Analysts Target Price | 32 | 8.4% |
ValueRay Target Price | 29.5 | -0.2% |